Data Centers of the International Council of Scientific Unions (ICSU) and chair of the ISCU group on Data and Information. He also directs the Data Information Unit for the World Ocean Circulation Experiment.
PETER N. WEISS has been a senior policy analyst/attorney in the Office of Information and Regulatory Affairs, Office of Management and Budget, since 1991. Mr. Weiss analyzes policy and legal issues involving information resources and information technology management, with particular emphasis on electronic data interchange (EDI) and electronic commerce. He is primary author of the information policy sections of OMB Circular No. A-130, “Management of Federal Information Resources,” and is a member of the administration's Electronic Commerce Working Group. He also serves as OMB desk officer for the Federal Acquisition Regulation (FAR) and the Defense FAR Supplement. Previously, Mr. Weiss was deputy associate administrator for procurement law, Office of Federal Procurement Policy; in this position, he analyzed legal and policy issues affecting the procurement process. Major projects included examination of legal and regulatory issues surrounding procurement automation, policies and FAR revisions to facilitate EDI, as well as ADP procurement legal and policy issues. From 1985 to 1990, Mr. Weiss was the assistant chief counsel for procurement and regulatory policy, Office of Advocacy, U.S. Small Business Administration, where he presented small business policy positions to federal agencies and Congress. From 1981 to 1985, Mr. Weiss was in private practice in Washington, D.C. Mr. Weiss holds a BA from Columbia University and a JD from the Catholic University of America, Columbus School of Law.
MYRA N. WILLIAMS became president and chief executive officer of Molecular Applications Group in April 1997. Prior to assuming this position, Dr. Williams was vice president and director of worldwide R&D Information Resources for Glaxo Wellcome, a position she assumed at the time of the merger of Glaxo with Wellcome. Before the merger, Dr. Williams was vice president and chief information officer of Glaxo Inc. Her accomplishments included providing leadership in the integration and globalization process after the merger; delivering major new applications including an integrated clinical information system and powerful tools supporting basic research; developing the foundation for a new business in healthcare informatics; and establishing the bioinformatics initiative in the United States. Prior to joining Glaxo, Dr. Williams was executive director of Information Resources and Strategic Planning at the Merck Research Laboratories. During her almost 24 years at Merck, she made contributions as a laboratory scientist in the application of biophysical techniques to drug design; led strategic planning for R&D; led the molecular modeling department in the development of improved approaches to computational chemistry and chemical data mining; and provided planning and coordination of information and computer resources including the publication of the Merck Index. Dr. Williams completed her BS at Southern Methodist University in 1964 in physics and mathematics and her PhD at Yale University in 1968 in molecular biophysics.